WallStreetZenWallStreetZen

NASDAQ: WINT
Windtree Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for WINT

Based on 1 analyst offering 12 month price targets for Windtree Therapeutics Inc.
Min Forecast
$1.00+180.9%
Avg Forecast
$1.00+180.9%
Max Forecast
$1.00+180.9%

Should I buy or sell WINT stock?

Based on 1 analyst offering ratings for Windtree Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their WINT stock forecasts and price targets.

WINT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-03

1 of 1

Forecast return on equity

Is WINT forecast to generate an efficient return?
Company
N/A
Industry
-53.34%
Market
20.29%

Forecast return on assets

Is WINT forecast to generate an efficient return on assets?
Company
N/A
Industry
4.7%

WINT revenue forecast

What is WINT's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$87.3M

WINT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WINT$0.36$1.00+180.90%Hold
AMPE$2.30N/AN/A
VRAX$0.96N/AN/A
ENVB$0.83$10.00+1,103.37%Buy
ALLR$0.43N/AN/A

Windtree Therapeutics Stock Forecast FAQ

Is Windtree Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: WINT) stock is to Hold WINT stock.

Out of 1 analyst, 0 (0%) are recommending WINT as a Strong Buy, 0 (0%) are recommending WINT as a Buy, 1 (100%) are recommending WINT as a Hold, 0 (0%) are recommending WINT as a Sell, and 0 (0%) are recommending WINT as a Strong Sell.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

What is WINT's revenue growth forecast for 2030-2030?

(NASDAQ: WINT) Windtree Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.16%.

Windtree Therapeutics's revenue in 2024 is $0.

In 2030, WINT is forecast to generate $449,439,519 in revenue, with the lowest revenue forecast at $449,439,519 and the highest revenue forecast at $449,439,519.

What is WINT's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: WINT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 4.7%.

What is WINT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year WINT price target, the average WINT price target is $1.00, with the highest WINT stock price forecast at $1.00 and the lowest WINT stock price forecast at $1.00.

The Wall Street analyst predicted that Windtree Therapeutics's share price could reach $1.00 by Jan 3, 2025. The average Windtree Therapeutics stock price prediction forecasts a potential upside of 180.9% from the current WINT share price of $0.36.

What is WINT's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: WINT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.